Vitamin K1 (phylloquinone) and K2 (menaquinone-4) supplementation improves bone formation in a high-fat diet-induced obese mice

Journal of Clinical Biochemistry and Nutrition

Volumn 53, Issue 2, 2013, Pages 108-113

  Kim, Misung ^a   Na, Woori ^a   Sohn, Cheongmin ^a  

^a Wonkwang University   (South Korea)

Author keywords

Bone density; Obesity; Osteoblast; Osteoclast; Vitamin K

Indexed keywords

BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; MENATETRENONE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHYTOMENADIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METABOLISM; BONE TURNOVER; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; VITAMIN SUPPLEMENTATION;

EID: 84885127847     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-25     Document Type: Article

References (33)

1. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162: 2269-2276. (Pubitemid 35332510)
2. Statistics Korea. Household projections for Korea: 2005-2030, 2012.
3. Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012; 308: 1150 - 1159.
4. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med 1992; 116: 535-539.
5. Lavie CJ, Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest 1986; 90: 275-279. (Pubitemid 16040585)
6. Joakimsen RM, Fenneba V, Magnus JH, Tollan A, Sogaard AJ. The Tromso Study: body height, body mass index and fractures. Osteoporos Int 1998; 8: 436-442. (Pubitemid 28486711)
7. Johnell O, Gullberg B, Kanis JA, et al. Risk factors for hip fracture in European women: The MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res 1995; 10: 1802-1815.
8. Fujiwara S, Kasagi F, Yamada M, Kodama K. Risk factors for hip fracture in a Japanese cohort. J Bone Miner Res 1997; 12: 998-1004. (Pubitemid 27264212)
9. Kim KC, Shin DH, Lee SY, Im JA, Lee DC. Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J 20\0; 51: 857-863.
10. Lee JS, Kawakubo K, Sato H, Kobayashi Y, Haruna Y. Relationship between total and regional bone mineral density and menopausal state, body composition and life style factors in overweight Japanese women. Int J Obes Relat Metab Disord 2001; 25: 880-886. (Pubitemid 32601382)
11. Toth E, Ferenc V, Meszaros S, Csupor E, Horvith C. Effects of body mass index on bone mineral density in men. Orv Hetil 2005; 146: 1489-1493. (Pubitemid 46118682)
12. Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006; 83: 146-154. (Pubitemid 44699248)
13. Koshihara Y, Hoshi K, Okawara R, Ishibashi H, Yamamoto S. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol 2003; 176: 339-348. (Pubitemid 36410418)
14. Bessette L, Jean S, Lapointe-Garant MP, et al. Direct medical costs attribut- able to peripheral fractures in Canadian post-menopausal women. Osteoporos Int 2012; 23: 1757-1768.
15. Berkner KL. The vitamin K-dependent carboxylase. Annu Rev Nutr 2005; 25: 127-149. (Pubitemid 41208997)
16. Apalset EM, Gjesdal CG, Eide GE, Tell GS. Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. Bone 2011; 49: 990-995.
17. Booth SL, Broe KE, Gagnon DR, et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 2003; 77: 512-516. (Pubitemid 36133397)
18. Katsuyama H, Otsuki T, Tomita M, et al. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med 2005; 15: 231-236.
19. Sasaki N, Kusano E, Takahashi H, et al. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab 2005; 23:41-47.
20. Morishita M, Nagashima M, Wauke K, Takahashi H, Takenouchi K. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. J Rheumatol 2008; 35: 407-413. (Pubitemid 351374412)
21. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS. Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 1998; 47: 1089-1096. (Pubitemid 28428014)
22. Martin-Badosa E, Amblard D, Nuzzo S, Elmoutaouakkil A, Vico L, Peyrin F. Excised bone structures in mice: Imaging at three-dimensional synchrotron radiation micro CT. Radiology 2003; 229: 921-928. (Pubitemid 37467602)
23. Fujikawa T, Sakurai T, Kashima I. Effects of a supplement containing vitamin K2 (MK7) and calcium phosphate (salmon bone powder) on the femur trabecular structure in ovariectomized mice: A study using three-dimensional imaging analysis. Oral Radiology 2004; 20: 37-43. (Pubitemid 38980965)
24. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000; 15:515-521. (Pubitemid 30134096)
25. Iwamoto I, Kosha S, Noguchi S, et al. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas 1999; 31: 161-164. (Pubitemid 29074386)
26. Young HE, Mancini ML, Wright RP, et al. Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 1995; 202: 137-144.
27. Kim MS, Lee HA, Kim OJ, Sohn CM. Relationship between of bone morphological microstructure and inflammatory markers in growing mice fed on a high fat diet. Korean J Nutr 2011; 44: 481-487.
28. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone Gla-protein: A specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984; 1: 1091-1093. (Pubitemid 14100805)
29. Patsch JM, Kiefer FW, Varga P, et al. Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metabolism 2011; 60: 243-249.
30. Khosla S, Arrighi HM, Melton LJ 3rd, et al. Correlates of osteoprotegerin levels in women and men. Osteoporos Int 2002; 13: 394-399. (Pubitemid 34625396)
31. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319. (Pubitemid 27199902)
32. Kim M, Kim H, Sohn C. Relationship between vitamin K status, bone mineral density, and hs-CRP in young Korean women. Nutr Res Pract 2010; 4: 507-514.
33. Yamaguchi M, Taguchi H, Gao YH, igarashi A, Tsukamoto Y. Effect of vitamin K2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats. J Bone Miner Metab 1999; 17: 23-29. (Pubitemid 29117748)